Defence Therapeutics Inc. (DTC.CN)
CAD 0.52
(0.0%)
CAD 0.52
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 7871.00 CAD | -99.55% |
| 2022 | 1.74 Million CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q3 | 15.39 Thousand CAD | -31.85% |
| 2023 Q4 | 7871.00 CAD | -48.89% |
| 2023 Q1 | 1.63 Million CAD | -6.19% |
| 2023 Q2 | 22.59 Thousand CAD | -98.62% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 Q4 | 1.74 Million CAD | 6.3% |
| 2022 Q3 | 1.64 Million CAD | -4.63% |
| 2022 Q2 | 1.72 Million CAD | 0.0% |
| 2022 FY | 1.74 Million CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | - CAD | -Infinity% |
| Asep Medical Holdings Inc | - CAD | -Infinity% |
| BetterLife Pharma Inc. | 245.23 Thousand CAD | 96.79% |
| BioVaxys Technology Corp. | - CAD | -Infinity% |
| ChitogenX Inc. | 3.27 Million CAD | 99.76% |
| Rapid Dose Therapeutics Corp. | 2.12 Million CAD | 99.63% |
| Entheon Biomedical Corp. | - CAD | -Infinity% |
| Gemina Laboratories Ltd. | 205.98 Thousand CAD | 96.179% |
| Glow Lifetech Corp. | - CAD | -Infinity% |
| Lexston Life Sciences Corp. | - CAD | -Infinity% |
| Pharmala Biotech Holdings Inc. | - CAD | -Infinity% |
| Doseology Sciences Inc. | - CAD | -Infinity% |
| MYND Life Sciences Inc. | - CAD | -Infinity% |
| Nova Mentis Life Science Corp. | - CAD | -Infinity% |
| PharmaTher Holdings Ltd. | - CAD | -Infinity% |
| PreveCeutical Medical Inc. | - CAD | -Infinity% |
| Telescope Innovations Corp. | - CAD | -Infinity% |